Table 2. Percutaneous destruction of bone lesions.
| Variables | Modality | N (%) | Estimate DLP delivered after multiparry adjustment (95% CI) (mGy·cm) | P value |
|---|---|---|---|---|
| Age (years) | <25 | 47 (31.3) | 526.4 (333.4–831.2) | 0.0082 |
| ≥25, <46 | 49 (32.7) | 589.0 (374.9–925.2) | ||
| ≥46 | 54 (36.0) | 794.9 (502.7–1,256.9) | ||
| Location | Pelvis | 28 (18.7) | 858.6 (529.1–1,393.2) | <0.0001 |
| Shoulder girdle | 4 (2.7) | 791.8 (393.5–1,593.4) | ||
| Hand | 9 (6.0) | 469.1 (271.8–809.6) | ||
| Lower limb (except foot) | 51 (34.0) | 557.6 (355.0–876.0) | ||
| Upper limb (except hand) | 16 (10.7) | 657.7 (402.0–1,076.2) | ||
| Foot | 15 (10.0) | 253.8 (155.4–414.3) | ||
| Spine | 21 (14.0) | 1,015.4 (620.5–1,661.6) | ||
| Sternocostal | 6 (4.0) | 792.2 (427.6–1,467.7) | ||
| Gender | Women | 62 (41.3) | 653.9 (417.1–1,025.2) | 0.3736 |
| Men | 88 (58.7) | 601.2 (384.7–939.5) | ||
| Technique | Cryotherapy | 36 (24.0) | 922.8 (555.0–1,534.6) | 0.1864 |
| Laser | 19 (12.7) | 460.6 (156.8–1,353.2) | ||
| RFA | 95 (63.3) | 579.8 (384.6–874.1) |
DLP, dose length product; CI, confidence interval; RFA, radiofrequency ablation.